Lineage Cell Therapeutics Stock Forecast

Sell candidate since Jun 15, 2026 Gain 1.63%

The Lineage Cell Therapeutics, Inc. stock price gained 4.17% on the last trading day (Wednesday, 17th Jun 2026), rising from $1.20 to $1.25. During the last trading day the stock fluctuated 4.10% from a day low at $1.22 to a day high of $1.27. The price has risen in 6 of the last 10 days and is up by 4.17% over the past 2 weeks. Volume fell on the last day by -222 thousand shares and in total, 967 thousand shares were bought and sold for approximately $1.21 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -22.38% during the next 3 months and, with a 90% probability hold a price between $0.88 and $1.11 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

LCTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, June 05, 2026, and so far it has risen 5.04%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lineage Cell Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.30. On a fall, the stock will find some support from the short-term average at $1.24. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Lineage Cell Therapeutics, Inc. stock

Lineage Cell Therapeutics, Inc. finds support from accumulated volume at $1.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0500 between high and low, or 4.10%. For the last week the stock has had daily average volatility of 5.11%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LCTX) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Lineage Cell Therapeutics, Inc. to open at $1.25, and during the day (based on 14 day Average True Range), to move between $1.21 and $1.29, which gives a possible trading interval of +/-$0.0718 (+/-5.91%) up or down from last closing price. If Lineage Cell Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.23 (1.60%) than the resistance at $1.31 (4.80%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Lineage Cell Therapeutics, Inc. stock A Buy?

Lineage Cell Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.888 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 18, 2026 - $1.25 ( 0.267%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk